Results 201 to 210 of about 12,440,936 (400)

Case for Diagnosis [PDF]

Proceedings of the Royal Society of Medicine, 1913
openaire   +9 more sources

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source

Exploring Parental Experiences of Childhood Ear Health Clinics and Their Acceptability of AI-Based Diagnostic Tools: A Qualitative Study. [PDF]

Health Expect
Stephens JH, Northcott C, Machell A, Lewis T, Ooi EH.   +4 more
europepmc   +1 more source

LI. Diagnosis and Treatment of Diphtheria [PDF]

, 1913
Joseph B. Greene
openalex   +1 more source

The influence of ROS1 fusion partners and resistance mechanisms in ROS1‐TKI‐treated non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga, Christa Dijkhuizen, Patrick Korthuis, Wim Timens, Harry Groen, Jeroen Hiltermann, Anke van den Berg, Lyndsay Drayer, Anthonie van der Wekken   +8 more
wiley   +1 more source

Diagnosis? [PDF]

Canadian Journal of Infectious Diseases and Medical Microbiology, 1999
T Lambert, JM Langley, A Issekutz
openaire   +7 more sources

What is the economic burden of delayed axial spondyloarthritis diagnosis in the UK? [PDF]

Rheumatology (Oxford)
Zanghelini F, Xydopoulos G, Howard Wilsher S, Afolabi O, Webb D, Eddison J, Ingram TA, Clark C, Hamilton J, Sengupta R, Gaffney K, Fordham R.   +11 more
europepmc   +1 more source

XLIX. Report of a Case of Thrombosis of the Superior Petrosal Sinus of Otitic Origin, Presenting a Symptom Complex Strongly Suggesting the Diagnosis [PDF]

, 1922
William G. Shemeley
openalex   +1 more source

Hypomethylating agents increase L1 retroelement expression without inducing novel insertions in myeloid malignancies

Molecular Oncology, EarlyView.
We investigated whether hypomethylating agents (HMAs) used in myeloid malignancies induce somatic retrotransposition. Our findings indicate that HMA treatment increases L1‐encoded protein expression but does not lead to detectable de novo retrotransposition events in either patient samples or cell lines.
Šárka Pavlová, Hana Svozilová, Marcela Krzyžánková, Radim Sonnek, Anastasiya Volakhava, Anastasia Smirnova, Tatiana Grigoreva, Zuzana Jašková, Hana Synáčková, Dennis Wahl, Michaela Bilčíková, Libor Červinek, Šárka Pospíšilová, Ilgar Mamedov, Karla Plevová   +14 more
wiley   +1 more source

Impact of Physical Activity on Metastatic Cancer at Diagnosis and Mortality: Results from the Lifelines Cohort Study. [PDF]

Cancer Epidemiol Biomarkers Prev
Bos MD, Sidorenkov G, Vinke PC, Ho CSL, Meyer NH, Bockhorn M, de Groot DJA, Klaase JM, Hoogwater FJH, de Bock GH, Nijkamp MW.   +10 more
europepmc   +1 more source